Institute Of Infectious Disease and Molecular Medicine
2022-06-13 12:24
Institute Of Infectious Disease and Molecular Medicine
For information on South Africas response to COVID-19 please visit the
COVID-19 Corona Virus South African Resource Portal
The childhood cough that kills- a review of respiratory related mortality-
Establishment of a Patient-Derived, Magnetic Levitation-Based, 3D Spheroid Granuloma Model for Human Tuberculosis-
Treatment of HIV associated cryptococcal meningitis: Results of the Ambition-CM trial & Prevention of HIV associated cryptococcal meningitis: The Effect trial-
Exploiting the uniqueness of the soloMERTM technology for the development of next-generation, super-potent drug modalities for chronic autoimmune inflammation diseases, and beyond-
Opportunities and Challenges in Early-Stage TB Drug Discovery: Targeting DNA Replication as a Case Study-
The next phase of African scientific capacity development. Lessons learned over a year building an African biotech startup-
Clinical Biomarker Discovery - Translational Biomarkers in Rheumatic Diseases and Neuroinflammation-
Mycobacterium tuberculosis (Mtb)-specific cytokine and antibody responses in healthcare workers resistant to Mtb infection despite sustained occupational exposure-
Use of whole genome sequencing for second-line treatment of drug-resistant tuberculosis-
Capture and visualization of live Mycobacterium tuberculosis bacilli from tuberculosis patient bioaerosols-